Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Beigene Ltd ADR (BGNE)

Beigene Ltd ADR (BGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Beigene Ltd ADR 94 SOLARIS AVENUE CAMANA BAY GRAND CAYMAN E9 KY1-1108 CYM

www.beigene.com Employees: 10,600 P: 345-949-4123

Description:

BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company's clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands.

Key Statistics

Overview:

Market Capitalization, $K 20,174,338
Enterprise Value, $K 17,877,058
Shares Outstanding, K 97,343
Annual Sales, $ 2,459 M
Annual Net Income, $ -881,710 K
Last Quarter Sales, $ 929,170 K
Last Quarter Net Income, $ -120,410 K
EBIT, $ -883,150 K
EBITDA, $ -795,470 K
60-Month Beta 0.63
% of Insider Shareholders 7.43%
% of Institutional Shareholders 48.55%
Float, K 90,110
% Float 92.57%
Short Volume Ratio 0.71

Growth:

1-Year Return 13.20%
3-Year Return -45.27%
5-Year Return 4.54%
5-Year Revenue Growth 1,140.43%
5-Year Earnings Growth 30.45%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.15 on 08/07/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -5.08
EPS Growth vs. Prev Qtr 52.28%
EPS Growth vs. Prev Year 68.41%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BGNE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -14.93%
Return-on-Assets % -9.22%
Profit Margin % -35.86%
Debt/Equity 0.06
Price/Sales 8.08
Price/Cash Flow N/A
Price/Book 5.88
Book Value/Share 34.72
Interest Coverage -0.45
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar